Awakening «dormant» cells to fight cancer
A team from the UNIGE and the HUG has succeeded in identifying a drug-targetable mechanism whose blockage reduces the capacity of melanoma cells to adapt and resist to treatment
27-Sep-2022 -
The advent of small-molecule targeted therapies, a decade ago, revolutionized the treatment of metastatic melanoma, provided that the tumors carry the mutations to respond to these treatments. However, despite a remarkable initial response that can be seen in a majority of patients, most of them ...
metastatic melanoma
proteins
tumors